Clinical Progression of High-Grade Cervical Intraepithelial Neoplasia: Estimating the Time to Preclinical Cervical Cancer From Doubly Censored National Registry Data

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

(2014) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis

(2012) Mariëlle Kocken et al.   GYNECOLOGIC ONCOLOGY

Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management

(2012) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening

(2012) Veerle M.H. Coupé et al.   VACCINE

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases

(2011) M Gök et al.   BRITISH JOURNAL OF CANCER

Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence

(2011) Johannes A. Bogaards et al.   EPIDEMIOLOGY

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

The health and economic effects of HPV DNA screening in The Netherlands

(2010) Johannes Berkhof et al.   INTERNATIONAL JOURNAL OF CANCER

Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?

(2010) Inge M.C.M. de Kok et al.   INTERNATIONAL JOURNAL OF CANCER

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Incorporating frailty in a multi-state model: application to disease natural history modelling of adenoma-carcinoma in the large bowel

(2010) Amy MF Yen et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

(2009) Ralph P Insinga et al.   BMC INFECTIOUS DISEASES

How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands

(2009) Veerle M.H. Coupé et al.   VACCINE

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

(2008) V M H Coupé et al.   BRITISH JOURNAL OF CANCER

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

(2008) Peter Sasieni et al.   INTERNATIONAL JOURNAL OF CANCER

Heterogeneity in CIN3 diagnosis

(2008) Mark Schiffman et al.   LANCET ONCOLOGY

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY

Health and Economic Implications of HPV Vaccination in the United States

(2008) Jane J. Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE